Genetic Testing Among Medicaid-Insured Children With Autism and Intellectual Disability
Autism spectrum disorder (ASD) and intellectual disability (ID) are pediatric conditions that benefit from early diagnosis and treatment,1 and professional society guidelines recommend etiological genetic testing upon diagnosis.2,3 A genetic diagnosis can enhance medical surveillance and lead to actionable therapies and specialized care.2,4 Understanding factors affecting access to genetic testing is essential to ensure these benefits for individuals with ASD and/or ID. This cohort study examines testing frequency among children with ASD and/or ID across demographic factors using Medicaid claims data.